Associate Professor Jane Davies

Principal Research Fellow

Qualifications:

PhD, Charles Darwin University, 2016; Post Graduate Certificate in Teaching and Learning in Clinical Practice, University of Chester, 2009; Diploma in Tropical Medicine and Hygiene, Liverpool School of Tropical Medicine, 2007; Member of the Royal College of Physicians (UK), 2006; MBBS Bachelor of Medicine, Bachelor of Surgery, University of Newcastle-upon-Tyne, UK, 2002.

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Dr Davies is a clinical researcher with over ten years’ experience in the area of Global Health and Infectious Diseases. Dr Davies has an extensive clinical background in these areas including working in communities in Tanzania, Malawi, England. 

Northern Territory, Australia. Dr Davies was awarded her PhD in 2016 which centred on Hepatitis B in the Northern Territory (NT) with a particular focus on Indigenous Australians.

She was instrumental in establishing and is now co-leader of the collaborative hepatitis B research program based at Menzies. Her research incorporates clinical and molecular epidemiology as well as health education for Indigenous communities. She also works clinically as an Infectious Diseases and General Medicine specialist physician at Royal Darwin Hospital.

Associate Professor Jane Davies
Email
Research Themes
  1. Littlejohn, M., Davies, J., Yuen, L., Edwards, R., Sozzi, T., Jackson, K., et al. (2014). Molecular Virology of Hepatitis B virus Sub-Genotype C4 in Northern Australian Indigenous Population. Journal of Medical Virology, 4(86), 695-706.
  2. Davies, J., Majumdar, S.S., Forbes, R., Smith, P., Currie, B., & Baird, R. (2013). Hookworm in the Northern Territory: down but not out. Medical Journal of Australia,198(5), 278-281.
  3. Davies, J., Littlejohn, M., Locarnini, S., Whiting, S., Hajkowicz, K., Cowie, B., et al. T (2013). The molecular epidemiology of Hepatitis B in the Indigenous people of northern Australia. Journal of Gastroenterology and Hepatology, 28,1234-1241.
  4. Davies, J, Tong SYC, Hajkowicz K, Bowden S, Locarnini S, & Davis JS. (2013). Hepatitis D is rare or non-existent in hepatitis B virus infected Indigenous Australians in the Northern Territory. Australian and New Zealand Journal of Public Health, 37(2),188-189.
  5. Henman, K., Gordon, C., Gardiner, T., Thorn, J., Spain, B., Davies, J., & Baird, R.(2012). Surgical Site Infections Following Caesarean Section at Royal Darwin Hospital, Northern Territory. Healthcare Infection, 17, 47-51.
  6. Davies, J.*, Gordon, C.*, Tong, S., Baird, R. & Davis, J. (2012). Impact of Results of a Rapid Staphylococcus aureus Diagnostic Test on Prescribing of Antibiotics for Patients with Clustered Gram-Positive Cocci in Blood cultures. Journal of Clinical Microbiology, 50(6), 2056-2058.
  7. Davies, J., Jabbar, Z., Gagan, F., & Baird, R.W. (2012). Blood Borne Viruses in the haemodialysis dependent population attending Top End Northern Territory facilities 2000-2009. Nephrology, 17, 501-507.
  8. Van der Maaten, G.C., Davies ,J., Nyirenda, M., Chitani, A., Allain, T.J., Beeching, N.J., Beadsworth, M.B.J., & van Oosterhout, J.J. (2011). HIV post exposure prophylaxis programmes in the developed and developing world: can we learn from each other?  International Journal of STD & AIDS, 22(12), 751-752.
  9. Moore, E., Beadsworth, M.B.J., Chaponda, M., Mhango, B., Faragher, B., Njala, J., Hofland, H.W.C, Davies, J., et al. (2010). Favourable one-year ART outcomes in adult Malawians with Hepatitis B and C co-infection. Journal of Infection, 61(2),155-63. [Epub 2010 May 12].
  10. Davies, J., van Oosterhout, J.J., Nyirenda, M., Bowden, J., Moore, E., Hart, I.J., et al. (2010). Reliability of rapid testing for hepatitis B in a region of high HIV endemicity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(2), 162-164.
Click here to view more Jane Davies publications in PubMed.
  1. MEDIA RELEASE | Flu vaccine elicits robust immune responses in Aboriginal and Torres Strait Islander populations

    MEDIA RELEASE | Flu vaccine elicits robust immune responses in Aboriginal and Torres Strait Islander populations

    Date

    For the first time, researchers have found the influenza vaccine to be just as effective in Aboriginal and Torres Strait Islander people as it is non-Indigenous people.

  2. COVID-19 vaccination video in Kunwinjku

    COVID-19 vaccination video in Kunwinjku

    Date

    Jeanette Burrunali from the Bininj Kunwok Regional Language Centre recently asked Dr Jane Davies lots of questions about the vaccine, questions that people want to know the answers to.

  3. Northern Territory: the little health system that could (beat COVID-19)

    Northern Territory: the little health system that could (beat COVID-19)

    Date

    The Northern Territory has done as well as any health system in the country at flattening the COVID-19 curve. Dr Nick Douglas and his colleagues discuss with MJA how this was achieved.

  4. Hep B Past Bulletin | Issue 1

    Hep B Past Bulletin | Issue 1

    Date

    Welcome to the first official Hep B PAST Bulletin.

  5. AAMRI’s budget priority: secure the future of Australia’s next generation of talent

    AAMRI’s budget priority: secure the future of Australia’s next generation of talent

    Date

    Australian medical research institutes are raising the alarm about the precarious position facing our earlier-career scientists.

  6. Eliminating chronic hepatitis B in the NT

    Eliminating chronic hepatitis B in the NT

    Date

    Senior clinical research fellow, Dr Jane Davies, has dedicated the past eight years to eliminating the burden of chronic hepatitis B (CHB) in Aboriginal and Torres Strait Islander communities in the NT. CHB, a virus that causes inflammation of the liver, is endemic in communities. Approximately 25 per cent of cases lead to liver cancer and liver failure.

  7. $5.6m on health research

    $5.6m on health research

    Date

    Health Minister Greg Hunt Says Federal Government will invest $5.6 million in the NT for medical research.

  8. NT News | Funds for critical health issue studies

    NT News | Funds for critical health issue studies

    Date

    Report on Menzies NHMRC and MRFF Investigator grants.

  9. Five medical research projects recognised in the Northern Territory

    Five medical research projects recognised in the Northern Territory

    Date

    Five researchers based at Menzies have received recognition in the form of Investigator Grants from the NHMRC and the MRFF.

  10. $400 million funding boost for health and medical research

    $400 million funding boost for health and medical research

    Date

    Including Menzies School of Health Research work towards the elimination of chronic hepatitis B in the Northern Territory.

  11. Innovative data use an important step in eliminating hep B

    Innovative data use an important step in eliminating hep B

    Date

    A team of researchers in the Northern Territory (NT) have designed and tested a new algorithm to determine hepatitis B status.

  12. RDH set to trial cocktail of drugs

    RDH set to trial cocktail of drugs

    Date

    Menzies researcher and Co-director of infectious diseases at Royal Darwin and Palmerston Hospitals Dr Jane Davies said the two drugs have shown promising signs of working to fight the virus in test tubes.

  13. Researcher profile | Thank you Dr Jane Davies

    Researcher profile | Thank you Dr Jane Davies

    Date

    Dr Jane Davies, was instrumental in establishing the Menzies collaborative hepatitis B research program in the Northern Territory. Dr Davies is also the co-Director of Infectious Diseases at Royal Darwin Hospital (RDH), and has been an integral part of...

  14. Bininj Kunwok Regional Language Centre supports new phone App

    Bininj Kunwok Regional Language Centre supports new phone App

    Date

    Menzies School of Health Research in Darwin are making a new phone app about Hepatitis B in Kunwinjku language with help from the Bininj Kunwok Regional Language Centre.

  15. Coronavirus assistance to Pacific and Timor-Leste

    Coronavirus assistance to Pacific and Timor-Leste

    Date

    Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.

  16. Coronavirus assistance to Pacific and Timor-Leste

    Coronavirus assistance to Pacific and Timor-Leste

    Date

    Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.

  17. CAMERA2: Standard MRSA treatment does not outperform combination therapy

    CAMERA2: Standard MRSA treatment does not outperform combination therapy

    Date

    Standard treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infection is not more efficacious than combination therapy, according to new research published in JAMA.

  18. Trial shows using two drugs not better than one when treating MRSA blood infections

    Trial shows using two drugs not better than one when treating MRSA blood infections

    Date

    Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects.

  19. Trial shows using two drugs not better than one when treating MRSA blood infections

    Trial shows using two drugs not better than one when treating MRSA blood infections

    Date

    Researchers of methicillin-resistant Staphylococcus aureus (MRSA) blood infections say combination of two antibiotics was no better than one.

  20. Study supports minimal monitoring in Sofosbuvir-based therapy for HCV

    Study supports minimal monitoring in Sofosbuvir-based therapy for HCV

    Date

    Some patients receiving sofosbuvir-based therapy for hepatitis C virus (HCV) may not need standard monitoring with clinic visits and blood testing.

  21. ASID Annual Scientific Meeting deemed a success for NT

    ASID Annual Scientific Meeting deemed a success for NT

    Date

    The Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting 2019, held from 16–18 May, saw 450 attendees descend on the Darwin Convention Centre.

  22. CAAMA Podcast | Strong Voices Monday 25/09/2019

    CAAMA Podcast | Strong Voices Monday 25/09/2019

    Date

    Australian researchers have used current Hepatitis B virus genome sequences to map the movement of Aboriginal people into Australia. A senior research fellow at the Menzies school of health research discusses the research paper.

  23. Hepatitis B DNA Helps Trace History and Movement of First Australians

    Hepatitis B DNA Helps Trace History and Movement of First Australians

    Date

    The team found that hepatitis B virus isolated from these Aboriginal Australians is a unique strain called HBV/C4, which is not found anywhere else in the world.

  24. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  25. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  26. Hepatitis B virus sheds light on ancient human population movements into Australia

    Hepatitis B virus sheds light on ancient human population movements into Australia

    Date

    Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia, adding weight to the theory that the mainland Aboriginal population separated from other early humans at least 59 thousand years ago and possibly entered the country near the Tiwi Islands.

  27. Dr Jane Davies - Higher Degrees by Research

    Dr Jane Davies - Higher Degrees by Research

    Date

    Dr Davies is a clinical researcher with over ten years’ experience in the area of Global Health and Infectious Diseases. Dr Davies has an extensive clinical background in these areas including working in and with communities in Tanzania, Malawi, England and the Northern Territory, Australia.

  28. NT News | Hope to eradicate chronic Hep B

    NT News | Hope to eradicate chronic Hep B

    Date

    NT News | Hope to eradicate chronic Hep B

  29. Chronic hepatitis B elimination partnership launched

    Chronic hepatitis B elimination partnership launched

    Date

    A collaboration working to eliminate chronic hepatitis B (CHB) from the Aboriginal and Torres Strait Islander population in the Northern Territory (NT) is being launched by NT Health Minister the Hon Natasha Fyles.

  30. Making hepatitis B information more widely available to Indigenous communities

    Making hepatitis B information more widely available to Indigenous communities

    Date

    Menzies is doing its part to ensure more Indigenous Territorians have access to potentially life-saving information about hepatitis B this World Hepatitis Day.

  31. Katherine Times | Making hepatitis B information more widely available to Indigenous communities

    Katherine Times | Making hepatitis B information more widely available to Indigenous communities

    Date

    Katherine Times | Making hepatitis B information more widely available to Indigenous communities

  32. Chronic hepatitis B to be eliminated from NT | Katherine Times

    Chronic hepatitis B to be eliminated from NT | Katherine Times

    Date

    An important collaboration which will work to eliminate chronic hepatitis B from the Aboriginal and Torres Strait Islander population in the NT has been established.

  33. Chronic hepatitis B to be eliminated from the Northern Territory

    Chronic hepatitis B to be eliminated from the Northern Territory

    Date

    An important collaboration which will work to eliminate chronic hepatitis B (CHB) from the Aboriginal and Torres Strait Islander population in the Northern Territory (NT) has been established.

  34. Scullion hails Indigenous health funding

    Scullion hails Indigenous health funding

    Date

    NT Senator Nigel Scullion - "funding continues the Coalition Government's strong commitment to supporting the best health and medical research."

  35. Indigenous Funding Boost | NT News

    Indigenous Funding Boost | NT News

    Date

    Menzies will use NHMRC funding to boost health outcomes of Indigenous Australians through two projects.

  36. Medical Republic | Hep C subsidised treatment 2nd Anniversary

    Medical Republic | Hep C subsidised treatment 2nd Anniversary

    Date

    It’s the second anniversary since the government subsidised the revolutionary treatments for hepatitis C, and tens of thousands of individuals were able to become free of the chronic disease.

  37. ABC online | Elcho Island researchers bound for Alaska

    ABC online | Elcho Island researchers bound for Alaska

    Date

    Three community-based researchers from Elcho Island working with Menzies School of Health Research are bound for Alaska to present at an international viral hepatitis conference.

  38. Severe hep B strain afflicts indigenous population

    Severe hep B strain afflicts indigenous population

    Date

    INDIGENOUS Territorians with hepatitis B suffer from an aggressive strain of the virus not found anywhere else in the world, researchers from Menzies School of Health Research have found.

  39. New app to improve treatment of Hepatitis B in remote Indigenous communities

    New app to improve treatment of Hepatitis B in remote Indigenous communities

    Date

    The launch of a new iPad app is hoping to address the prevalence and severity of Hepatitis B infections in remote Indigenous communities.